Pgen stock forecast earnings season could be a key catalyst

Earnings season could be a key catalyst for the PGEN stock forecast, with investor focus on EPS trends and pipeline disclosures. “Notable trims in the quarter included Papa John’s International, Inc. (NASDAQ:PZZA) Advanced Drainage and BlackLine. Papa John’s is a global operator and franchisor of pizza delivery and carryout restaurants. We originally invested in the company after a complete executive management team overhaul— notably, hiring a CEO, Rob Lynch, to spearhead a turnaround. Mr. Lynch brings previous leadership experience at large franchisors Arby’s and Taco Bell—where he worked alongside current Chipotle CEO Brian Niccol—and a marketing background at P&G. At Arby’s, Mr. Lynch led a turnaround effort where he shaped the company’s successful “We have the meats!” marketing campaign. Mr. Lynch has focused on reestablishing Papa John’s premium positioning with new food options, advertising campaigns and operational cost-cutting measures meant to improve margins. While we continue to believe in the long-term turnaround story, it is taking longer than we had originally expected. We began to harvest the position to fund higher conviction ideas.” Multiple analysts have issued price targets for $PGEN recently. We have seen 3 analysts offer price targets for $PGEN in the last 6 months, with a median target of $6.0. The biotech market's cyclic nature influences the PGEN stock forecast. Historically, stocks in early clinical trial stages show pronounced swings in response to headline data.